Mumps is a viral infection caused by mumps virus — a Paramyxovirus transmitted by respiratory droplets and saliva. The classic presentation is bilateral parotid gland swelling (parotitis) — causing the characteristic "chipmunk face" — accompanied by fever, malaise and headache. Parotitis typically appears 16-18 days after exposure. While generally a mild childhood illness, mumps can cause serious complications in post-pubertal individuals: orchitis (in approximately 25% of post-pubertal males), aseptic meningitis (approximately 10%), and rarely encephalitis or permanent deafness.

Why is mumps resurging despite high MMR coverage?

This is the central paradox of modern mumps epidemiology. Two-dose MMR is approximately 88% effective against mumps — substantially lower than its 97%+ effectiveness against measles. Moreover, mumps immunity wanes over 10-15 years post-vaccination. In crowded settings — university dormitories, military barracks, nightclubs — the combination of waning immunity and close contact enables transmission even among a largely vaccinated population. Major US university outbreaks (2016: Ivy League and Big Ten schools; 2018-2022: multiple large outbreaks) affected students who were fully vaccinated. A third MMR dose is now recommended in active outbreak settings.

What is mumps orchitis?

Orchitis — inflammation of one or both testes — is the most common serious complication in post-pubertal males, occurring in approximately 20-30% of cases. It typically appears 4-8 days after parotitis onset (but can occur without parotitis). Features: sudden severe testicular pain, swelling, tenderness, high fever (38-40°C), nausea. Unilateral in approximately 70%; bilateral in approximately 30%. Management: scrotal support, bed rest, ice, analgesics (NSAIDs). Testicular atrophy develops in approximately 30-50% of affected testes — but complete bilateral infertility is rare (<1% of bilateral orchitis cases).

How is mumps treated?

No antiviral treatment exists for mumps. Management is entirely supportive: Parotitis: analgesics (paracetamol or ibuprofen) for pain and fever; soft diet; adequate fluids; warm or cold compresses on the parotid. Orchitis: scrotal support (athletic supporter or rolled towel); bed rest; ice packs; analgesics/NSAIDs; corticosteroids sometimes used in severe cases (no proven benefit from trials). Meningitis: analgesics; fluids; hospital admission if vomiting prevents oral rehydration. Isolation: patients should be isolated for 5 days after onset of parotid swelling.

Is mumps dangerous in pregnancy?

Mumps in the first trimester of pregnancy is associated with an increased risk of spontaneous miscarriage. However, unlike rubella virus, mumps virus is NOT teratogenic — it does not cause congenital anomalies in surviving fetuses. There is no evidence that mumps causes deafness, heart defects or other birth defects in babies born to mothers with mumps. The main risk is miscarriage if infection occurs in the first trimester. MMR vaccine should NOT be given to pregnant women (live vaccine) — non-immune women should be vaccinated post-partum.

How does GMJ News cover mumps?

GMJ News covers WHO mumps data, the waning immunity paradox driving resurgence in vaccinated populations, third MMR dose in outbreaks, orchitis management, aseptic meningitis complication, sensorineural deafness risk, and MMR schedule. Mumps — once nearly eliminated, now resurging — illustrates the importance of sustained high MMR coverage and the challenge of waning vaccine-induced immunity in tightly clustered populations.

Home › Topics › Mumps

Mumps

Q: How is mumps treated?

No antiviral treatment exists for mumps. Management is entirely supportive: Parotitis: analgesics (paracetamol or ibuprofen) for pain and fever; soft diet; adequate fluids; warm or cold compresses on the parotid. Orchitis: scrotal support (athletic supporter or rolled towel); bed rest; ice packs; analgesics/NSAIDs; corticosteroids sometimes used in severe cases (no proven benefit from trials). Meningitis: analgesics; fluids; hospital admission if vomiting prevents oral rehydration. Isolation: patients should be isolated for 5 days after onset of parotid swelling.

Q: Is mumps dangerous in pregnancy?

Mumps in the first trimester of pregnancy is associated with an increased risk of spontaneous miscarriage. However, unlike rubella virus, mumps virus is NOT teratogenic — it does not cause congenital anomalies in surviving fetuses. There is no evidence that mumps causes deafness, heart defects or other birth defects in babies born to mothers with mumps. The main risk is miscarriage if infection occurs in the first trimester. MMR vaccine should NOT be given to pregnant women (live vaccine) — non-immune women should be vaccinated post-partum.

Q: How does GMJ News cover mumps?

GMJ News covers WHO mumps data, the waning immunity paradox driving resurgence in vaccinated populations, third MMR dose in outbreaks, orchitis management, aseptic meningitis complication, sensorineural deafness risk, and MMR schedule. Mumps — once nearly eliminated, now resurging — illustrates the importance of sustained high MMR coverage and the challenge of waning vaccine-induced immunity in tightly clustered populations.

GMJ News knowledge hub · last reviewed September 2026 · Georgian Medical Journal

Summary Statistics Glossary GMJ news FAQ Documents Organizations Research

Mumps — caused by mumps virus (Paramyxoviridae), transmitted by respiratory droplets — produces the characteristic bilateral parotid gland swelling (parotitis) giving the pathognomonic “chipmunk face” appearance, but is clinically important beyond this childhood inconvenience because of serious complications: orchitis in 20-30% of post-pubertal males, aseptic meningitis in approximately 10%, and irreversible sensorineural hearing loss — and because it has resurged dramatically even in highly vaccinated populations, with major university outbreaks in the US (2016-2022) and ongoing low-level European transmission, demonstrating that MMR-induced mumps immunity wanes more than immunity to measles or rubella (WHO). A third MMR dose is now recommended by the US CDC in outbreak settings to boost waning immunity.

Key messages

Waning MMR immunity — resurgence even in vaccinated

Mumps has resurged dramatically in highly vaccinated populations — thousands of cases in US universities 2016-2022, ongoing European outbreaks. MMR-induced mumps immunity wanes faster than measles or rubella immunity, requiring a third dose in outbreak settings (WHO/CDC).

Orchitis in 20-30% of post-pubertal males

Orchitis (testicular inflammation) — the most feared complication — occurs in 20-30% of post-pubertal males with mumps. Usually unilateral; bilateral orchitis (which can cause infertility) occurs in approximately 15-30% of orchitis cases. The swollen, tender testicle appears 4-8 days after parotitis onset.

Parotitis — the pathognomonic sign

Swelling of the parotid glands (preauricular and below the ear, pushing the ear lobe outward and upward) — unilateral or bilateral — is the defining clinical feature. Jaw pain on chewing and eating sour foods (lemon test). Parotitis appears 16-18 days after exposure.

Aseptic meningitis in ~10% — usually mild

Mumps aseptic meningitis occurs in approximately 10% of cases, often before or without parotitis. Usually self-limiting; rarely progresses to encephalitis (1-2/10,000 cases). Mumps was historically the most common cause of aseptic meningitis in pre-vaccine era children.

Sensorineural hearing loss — rare but permanent

Sudden-onset sensorineural hearing loss (SNHL) — usually unilateral — is a rare but permanent complication of mumps. Mumps was historically the most common cause of acquired unilateral SNHL in children. MMR vaccination essentially eliminated this complication in vaccinated populations.

No treatment — supportive care only

No antiviral treatment exists for mumps. Management: analgesics (paracetamol/ibuprofen) for parotitis pain and fever; scrotal support and ice for orchitis; adequate hydration. Isolation for 5 days after onset of parotid swelling.

Key statistics

20-30%

of post-pubertal males with mumps develop orchitis

WHO

~10%

develop aseptic meningitis (often without parotitis)

WHO/CDC

Thousands

of US university outbreak cases 2016-2022 despite high MMR coverage

CDC

3rd dose

MMR now recommended by CDC in active mumps outbreaks

CDC 2018

16-18 days

typical mumps incubation period (range 14-25 days)

WHO

approved antiviral treatment for mumps

WHO

Mumps complications — frequency in post-pubertal patients (WHO)

Source: WHO. Most complications occur in post-pubertal adults; MMR vaccination virtually eliminates them.

Glossary of key terms

Parotitis
WHO/ClinicalInflammation of the parotid salivary glands — the largest salivary glands, located in front of and below the ear. Mumps parotitis: swelling pushes the ear lobe outward and upward (pathognomonic direction); swelling extends to the angle of the jaw; bilateral in approximately 70% of cases (though may not be simultaneous). Exquisitely tender to palpation. Pain worsens markedly on eating sour or acidic foods (lemon/citric acid — the "lemon test").

Mumps orchitis
WHOTesticular inflammation occurring 4-8 days after parotitis onset, in 20-30% of post-pubertal males. Unilateral in approximately 70%; bilateral in approximately 30%. Features: fever, severe testicular pain and swelling. Testicular atrophy occurs in approximately 30-50% of affected testes. Bilateral orchitis rarely causes complete infertility but may reduce fertility.

Waning mumps immunity
CDC/ECDCUnlike measles immunity (essentially lifelong after 2 MMR doses), mumps immunity wanes over 10-15 years post-vaccination. Two-dose MMR achieves approximately 88% effectiveness against mumps (vs >97% for measles). In crowded settings (university dormitories, military barracks), waning immunity enables outbreaks among immunised populations. A third MMR dose is now recommended by CDC in active outbreak settings — boosts immunity to approximately 96%.

Stensen's duct
AnatomyThe parotid duct (Stensen's duct) opens into the buccal mucosa opposite the upper second molar. In mumps parotitis, the duct orifice appears red and swollen but pus is absent (distinguishing from bacterial parotitis). Palpation of the gland does not express purulent material (unlike bacterial parotitis).

Mumps in pregnancy
WHOMumps infection during the first trimester of pregnancy is associated with increased risk of spontaneous abortion (miscarriage). Unlike rubella, mumps does NOT cause fetal malformations (congenital anomalies). There is no specific antiviral treatment. Mumps in late pregnancy can cause fetal infection but does not cause the teratogenic syndrome seen with rubella.

MMR schedule
WHO/ACIPMeasles-Mumps-Rubella vaccine: dose 1 at 12-15 months; dose 2 at 4-6 years. Two doses achieve approximately 88% effectiveness against mumps (lower than the >97% against measles). A third dose in outbreak settings is recommended by CDC (2018 ACIP guidance) for adults in close-contact situations (college students, military personnel, healthcare workers).